CERTIFICATE

IMPACT FACTOR 2021

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

Assessment of acute gastro-intestinal and genito-urinary toxicities in the cervical cancer patients using cobalt-60 based high dose rate intra cavitary brachytherapy

Author: 
Jain Abhay Kumar, Rathore Narendra, Tanwar Rajendra Kumar, Shukla Arvind Kumar, Rajpurohit Vikram Singh and Gagrani Vaibhav
Subject Area: 
Health Sciences
Abstract: 

Context: Recently introduced Cobalt-60 HDR source has longer half life of 5.2 years compared with 73.8 days of Ir-192, more economical and attractive for low resource settings. Aim: The purpose of this study to know acute gastrointestinal and genitourinary toxicities associated with Co-60 source in HDR ICRT of cervical cancer patients and its comparison with similar toxicities in Ir-192 based HDR ICRT. Settings and Design: Prospective study Methods and Material: The study was completed on 65 patients of carcinoma cervix. External beam radiotherapy (EBRT) of dose 45-50 Gy in 25 fractions @ 180-200cGy per fraction delivered over 5 days per week using teletherapy Cobalt 60 machine. ICRT was started after one week of completion of EBRT. Fletcher suite applicators were used for brachytherapy in all patients. Total 3 sessions of ICRT, 7Gy each, were delivered 72 hours apart. The acute gastro-intestinal and genito-urinary toxicities were assessed using Common Terminology Criteria for Adverse Events version 4.03 (CTCAE). The only highest grade of GU and GI toxicity was used for final analysis and patients were kept in follow up for 3 months in this study. Statistical analysis used: Comparison with previous studies Results: Only 2 patients (3%) had grade 3 acute diarrhea. In other studies, the reported rates of acute toxicities ≥ grade 3 ranged from 0%–8% for gastrointestinal and 0%–3% for genitourinary toxicities. Conclusions: The acute gastrointestinal and genitourinary toxicities of high-dose-rate intracavitary brachytherapy using Co-60 radionuclide source is low and comparable with Iridium-192. Additionally, Cobalt 60 has economic advantage over Ir-192. Thus, it is more suitable for low economic resource settings.

PDF file: 

CALL FOR PAPERS

 

ONLINE PAYPAL PAYMENT

IJMCE RECOMMENDATION

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

 

EDITORIAL BOARD

CHUDE NKIRU PATRICIA
Nigeria
Dr. Swamy KRM
India
Dr. Abdul Hannan A.M.S
Saudi Arabia.
Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran